Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: Evidence based on a meta-analysis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 615-621

  He, Ya Zhou ^a   Hu, Xin ^a   Chi, Xiao Sa ^a   Zhang, Yuan Chuan ^a   Deng, Xiang Bing ^a   Wei, Ming Tian ^a   Wang, Zi Qiang ^a   Zhou, Yan Hong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute leukemia; Meta analysis; Myelodyspastic syndrome; RAD51 135G C

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; ETHNICITY; EVIDENCE BASED MEDICINE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RAD51 GENE;

ALLELES; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RAD51 RECOMBINASE;

EID: 84894429144     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1085-4     Document Type: Article

References (27)

1. Estey EH. Prognostic factors in acute myelogenous leukemia. Leukemia. 2001;15:670-2.
2. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937-51.
3. Wang LL, Gao C, Chen BA. Research progress on mechanism of MDS transformation into AML. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19:254-9.
4. Pedersen-Bjergaard J, Andersen MK, Andersen MT, Christiansen DH. Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2008;22:240-8.
5. Bjork J, Johansson B, Broberg K, Albin M. Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study. Leuk Res. 2009;33:788-91.
6. Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15:1083-101.
7. Kitamura T, Watanabe-Okochi N, Inoue D, Togami K, Uchida T, Kagiyama Y, et al. Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML). Jpn J Clin Hematol. 2012;53:734-9.
8. Finch SC. Radiation-induced leukemia: lessons from history. Best Pract Res Clin Hematol. 2007;20:109-18.
9. Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001;61:2542-6.
10. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411:366-74.
11. Agarwal S, TafelAA, Kanaar R.DNA double-strand break repair and chromosome translocations. DNA Repair. 2006;5:1075-81.
12. Baumann P, West SC. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci. 1998;23:247-51.
13. Thacker J. The RAD51 gene family, genetic instability, and cancer. Cancer Lett. 2005;219:125-35.
14. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res. 2005;577:275-83.
15. Richardson C. RAD51, genomic stability, and tumorigenesis. Cancer Lett. 2005;218:127-39.
16. KawabataM, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Med Okayama. 2005;59:1-9.
17. Rollinson S, Smith AG, Allan JM, Adamson PJ, Scott K, Skibola CF, et al. RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukemia. Leukemia Res. 2007;31:169-74.
18. Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res. 2004;10:2675-80.
19. Fabiani E, D'Alo F, Scardocci A, Greco M, Di Ruscio A, Criscuolo M, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res. 2009;33:1068-71.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327:557-60.
21. Li L, Yang L, Zhang Y, Xu Z, Qin T, Hao Y, et al. Detoxification and DNA repair genes polymorphisms and susceptibility of primary myelodysplastic syndromes in Chinese population. Leuk Res. 2011;35:762-5.
22. Baumann Kreuziger LM, Steensma DP. RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes. Am J Hematol. 2008;83:822-3.
23. Bhatla D, Gerbing RB, Alonzo TA,Mehta PA, Deal K, Elliott J, et al. DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group. Leukemia. 2008;22:265-72.
24. Hamdy MS, El-Haddad AM, Bahaa El-Din NM, Makhlouf MM, Abdel-Hamid SM. RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia. J Investig Med: the official publication of the American Federation for Clinical Research. 2011;59:1124-30.
25. Voso MT, Fabiani E, D'Alo F, Guidi F, Di Ruscio A, Sica S, et al. Increased risk of acute myeloid leukemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol. 2007;18:1523-8.
26. Yang L, Liu L, Mi YC, Li JY, Ma XT, Ai XF, et al. Relationship between RAD51-G135C/XRCC3-C241T polymorphisms and development of acute myeloid leukemia with recurrent chromosome translocation. Zhonghua Xueyexue Zazhi. 2011;32:299-303.
27. Zhang ZQ, Yang L, Zhang Y, Yang YH, Nie L, Li L, et al. Relationship between NQO1C(609T), RAD51(G135C), XRCC3(C241T) single nucleotide polymorphisms and acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17:523-8.